Identification of a late onset Alzheimer's disease candidate risk variant at 9q21.33 in polish patients

Journal of Alzheimer's Disease

Volumn 32, Issue 1, 2012, Pages 157-168

  Gaj, Pawel ^a   Paziewska, Agnieszka ^a   Bik, Wojciech ^b   Dbrowska, Michalina ^a   Baranowska Bik, Agnieszka ^b   Styczynska, Maria ^c   Chodakowska Ebrowska, Małgorzata ^d   Pfeffer Baczuk, Anna ^c   Barcikowska, Maria ^c   Baranowska, Boguslawa ^b   Ostrowski, Jerzy ^a  

^a INSTITUTE OF ONCOLOGY   (Poland)

^b MEDICAL CENTER FOR POSTGRADUATE EDUCATION   (Poland)

^c MOSSAKOWSKI MEDICAL RESEARCH CENTRE   (Poland)

^d CENTRAL CLINICAL HOSPITAL OF THE MINISTRY OF INTERIOR   (Poland)

Author keywords

APOE; DAPK1; genetic polymorphisms; genome wide association study; late onset Alzheimer's disease

Indexed keywords

APOLIPOPROTEIN E; APOLIPOPROTEIN E3; GENOMIC DNA;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CHROMOSOME 9Q21.33; CHROMOSOME ABERRATION; COHORT ANALYSIS; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC TEST ACCURACY STUDY; DNA DETERMINATION; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC SELECTION; GENETIC VARIABILITY; GENOTYPE; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MARKER GENE; MILD COGNITIVE IMPAIRMENT; MINI MENTAL STATE EXAMINATION; MULTIPLEX POLYMERASE CHAIN REACTION; MULTIPLEX TETRA PRIMER AMPLIFICATION REFRACTORY MUTATION SYSTEM POLYMERASE CHAIN REACTION; POLAND; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 84867556054     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-2012-120520     Document Type: Article

References (53)

1. Bertram L,TanziRE(2009) Genome-wide association studies in Alzheimer's disease. Hum Mol Genet 18, R137-R145.
2. Bertram L, Lill CM, Tanzi RE (2010) The genetics of Alzheimer disease: Back to the future. Neuron 68, 270-281.
3. Tanzi RE, Bertram L (2005) Twenty years of the Alzheimer's disease amyloid hypothesis: A genetic perspective. Cell 120, 545-555.
4. Goate A (2006) Segregation of a missense mutation in the amyloid beta-protein precursor gene with familial Alzheimer's disease. J Alzheimers Dis 9, 341-347.
5. Gough M, Parr-Srgess C, Parkin E (2011) Zinc metalloproteinasesand amyloid beta-peptide metabolism: The positive side of proteolysis in Alzheimer's disease. Biochem Res Int 2011, 1-13.
6. Raux G, Guyant-Maŕechal L, Martin C, Bou J, Penet C, Brice A, Hannequin D, Frebourg T, Campion D (2005) Molecular diagnosis of autosomal dominant early onset Alzheimer's disease: An update. J Med Genet 42, 793-795.
7. Olgiati P, Politis AM, Papadimitriou GN, De Ronchi D, Serretti A (2011) Genetics of late-onset Alzheimer's disease: Update from the alzgene database and analysis of shared pathways. Int J Alzheimers Dis 2011, 832379.
8. Mao P, Reddy PH (2011) Aging and amyloid beta-induced oxidative DNA damage and mitochondrial dysfunction in Alzheimer's disease: Implications for early intervention and therapeutics. Biochim Biophys Acta 1812, 1359-1370.
9. Styczýnska M, Strosznajder JB, Religa D, Chodakowska-Zebrowska M, Pfeffer A, Gabryelewicz T, Czapski GA, Kobrýs M, Karciauskas G, Barcikowska M (2008) Association between genetic and environmental factors and the risk of Alzheimer's disease. Folia Neuropathol 46, 249-254.
10. Pericak-Vance MA, Bebout JL, Gaskell PC Jr, Yamaoka LH, Hung WY, Alberts MJ, Walker AP, Bartlett RJ, Haynes CA, Welsh KA (1991) Linkage studies in familial Alzheimer disease: Evidence for chromosome 19 linkage. Am J Hum Genet 48, 1034-1050.
11. Farrer LA, Cupples LA, Haines JL, Hyman B, Kukull WA, Mayeux R, Myers RH, Pericak-Vance MA, Risch N, van DuijnCM(1997) Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease.Ameta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. JAMA 278, 1349-1356.
12. Reiman EM, Webster JA, Myers AJ, Hardy J, Dunckley T, Zismann VL, Joshipura KD, Pearson JV, Hu-Lince D, Huentelman MJ, Craig DW, Coon KD, Liang WS, Herbert RH, Beach T, Rohrer KC, Zhao AS, Leung D, Bryden L, Marlowe L, Kaleem M, Mastroeni D, Grover A, Heward CB, Ravid R, Rogers J, Hutton ML, Melquist S, Petersen RC, Alexander GE, Caselli RJ, Kukull W, Papassotiropoulos A, Stephan DA (2007) GAB2 alleles modify Alzheimer's risk in APOE -4 carriers. Neuron 54, 713-720.
13. Coon KD, Myers AJ, Craig DW, Webster JA, Pearson JV, Lince DH, Zismann VL, Beach TG, Leung D, Bryden L, Halperin RF, Marlowe L, Kaleem M, Walker DG, Ravid R, Heward CB, Rogers J, Papassotiropoulos A, Reiman EM, Hardy J, Stephan DA (2007) A high-density whole-genome association study reveals that APOE is the major susceptibility gene for sporadic late-onset Alzheimer's disease. J Clin Psychiatry 68, 613-618.
14. National Institute on Aging (2011) Alzheimer's disease genetics fact sheet, http://www.nia.nih.gov/alzheimers/ publication/alzheimers-disease- genetics-fact-sheet, Last updated April 9, 2012.
15. Petersen RC, Roberts RO, Knopman DS, Boeve BF, Geda YE, Ivnik RJ, Smith GE, Jack CR Jr (2009) Mild cognitive impairment: Ten years later. Arch Neurol 66, 1447-1455.
16. Petersen RC, Smith GE, Ivnik RJ, Tangalos EG, Schaid DJ, Thibodeau SN, Kokmen E, Waring SC, Kurland LT (1995) Apolipoprotein E status as a predictor of the development of Alzheimer's disease in memory-impaired individuals. JAMA 273, 1274-1278.
17. Alzheimer's Association (2012) 2012 Alzheimer's disease facts and figures. Alzheimers Dement 8, 131-168.
18. Genin E, Hannequin D, Wallon D, Sleegers K, Hiltunen M, Combarros O, Bullido MJ, Engelborghs S, De Deyn P, Berr C, Pasquier F, Dubois B, Tognoni G, Fíevet N, Brouwers N, Bettens K, Arosio B, Coto E, Del Zompo M, Mateo I, Epelbaum J, Frank-Garcia A, Helisalmi S, Porcellini E, Pilotto A, Forti P, Ferri R, Scarpini E, Siciliano G, Solfrizzi V, Sorbi S, Spalletta G, Valdivieso F, Veps̈al̈ainen S, Alvarez V, Bosco P, Mancuso M, Panza F, Nacmias B, Boss̀u P, Hanon O, Piccardi P, Annoni G, Seripa D, Galimberti D, Licastro F, Soininen H, Dartigues J-F, Kamboh MI, Van Broeckhoven C, Lambert JC, Amouyel P, Campion D (2011) APOE and Alzheimer disease: A major gene with semi-dominant inheritance. Mol Psychiatry 16, 903-907.
19. Yang YG, Kim JY, Park SJ, Kim SW, Jeon O-H, Kim D-S (2007) Apolipoprotein E genotyping by multiplex tetraprimer amplification refractory mutation system PCR in single reaction tube. J Biotechnol 131, 106-110.
20. Meaburn E, Butcher LM, Schalkwyk LC, Plomin R (2006) Genotyping pooled DNA using 100K SNP microarrays: A step towards genomewide association scans. Nucleic Acids Res 34, e27.
21. Affymetrix, Inc. (2005) Affymetrix®GeneChip® Genotyping Analysis Software User's Guide Version 4.0.
22. Chen B, Wilkening S, Drechsel M, Hemminki K (2009) SNP tools: A compact tool package for analysis and conversion of genotype data for MS-Excel. BMC Res Notes 2, 214.
23. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MAR, Bender D, Maller J, Sklar P, de Bakker PIW, Daly MJ, Sham PC (2007) PLINK: A tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 81, 559-575.
24. Barrett JC, Fry B, Maller J, Daly MJ (2005) Haploview: Analysis and visualization of LD and haplotype maps. Bioinformatics 21, 263-265.
25. Turner S (2011) Annotated Manhattan plots and QQ plots for GWAS using R, Revisited. Nature Precedings, doi:10.1038/npre.2011.6070.1.
26. Dupont WD, Plummer WD Jr (1990) Power and sample size calculations. A review and computer program. Control Clin Trials 11, 116-128.
27. Selkoe DJ (1989) The deposition of amyloid proteins in the aging mammalian brain: Implications for Alzheimer's disease. Ann Med 21, 73-76.
28. Osiecka KM, Nieznanska H, Skowronek KJ, Jozwiak J, Nieznanski K (2011) Tau inhibits tubulin oligomerization induced by prion protein. Biochim Biophys Acta 1813, 1845-1853.
29. Schmitt K, Grimm A, Kazmierczak A, Strosznajder JB, G̈otz J, Eckert A (2012) Insights into mitochondrial dysfunction: Aging, amyloid-, and tau-a deleterious trio. Antioxid Redox Signal 16, 1456-1466.
30. Czyzewski K, Pfeffer A, BarcikowskaM(1998) [Apolipoprotein E function in the nervous system]. Neurol Neurochir Pol 32, 125-132.
31. Braak H, Thal DR, Ghebremedhin E, Del Tredici K (2011) Stages of the pathologic process in Alzheimer disease: Age categories from 1 to 100 years. J Neuropathol Exp Neurol 70, 960-969.
32. Keeney JTR, Swomley AM, Harris JL, Fiorini A, Mitov MI, Perluigi M, Sultana R, Butterfield DA (2011) Cell cycle proteins in brain in mild cognitive impairment: Insights into progression to Alzheimer disease. Neurotox Res, doi: 10.1007/s12640-011-9287-2.
33. Emilsson L, Saetre P, Balciuniene J, Castensson A, Cairns N, Jazin EE (2002) Increased monoamine oxidase messenger RNA expression levels in frontal cortex of Alzheimer's disease patients. Neurosci Lett 326, 56-60.
34. Takehashi M, Tanaka S, Masliah E, Ueda K (2002) Association of monoamine oxidase A gene polymorphism with Alzheimer's disease and Lewy body variant. Neurosci Lett 327, 79-82.
35. Oliveira JRM, Nishimura AL, Lemos RR, ZatzM(2008) The genetics of Alzheimer's disease in Brazil: 10 years of analysis in a unique population. J Mol Neurosci 37, 74-79.
36. Nishimura AL, Guindalini C, Oliveira JRM, Nitrini R, Bahia VS, de Brito-Marques PR, Otto PA, Zatz M (2005) Monoamine oxidase a polymorphism in Brazilian patients: Risk factor for late-onset Alzheimer's disease? J Mol Neurosci 27, 213-217.
37. Wu Y-H, Fischer DF, Swaab DF (2007) A promoter polymorphism in the monoamine oxidaseAgene is associated with the pineal MAOA activity in Alzheimer's disease patients. Brain Res 1167, 13-19.
38. McPherson R (2009) A gene-centric approach to elucidating cardiovascular risk. Circ Cardiovasc Genet 2, 3-6.
39. Maruszak A, ? Zekanowski C (2011) Mitochondrial dysfunction and Alzheimer's disease. Prog Neuropsychopharmacol Biol Psychiatry 35, 320-330.
40. de-Almada BVP, de-Almeida LD, Camporez D, de-Moraes MVD, Morelato RL, Perrone AMS, Belcavello L, Louro ID, de-Paula F (2012) Protective effect of the APOE-e3 allele in Alzheimer's disease. Braz J Med Biol Res 45, 8-12.
41. Myllykangas L, Polvikoski T, Reunanen K, Wavrant-De Vrieze F, Ellis C, Hernandez D, Sulkava R, Kontula K, Verkkoniemi A, Notkola I-L, Hardy J, Perez-Tur J, Haltia MJ, Tienari PJ (2002) APOE epsilon3-haplotype modulates Alzheimer beta-amyloid deposition in the brain. Am J Med Genet 114, 288-291.
42. Cruchaga C, Nowotny P, Kauwe JSK, Ridge PG, Mayo K, Bertelsen S, Hinrichs A, Fagan AM, Holtzman DM, Morris JC, Goate AM (2011) Association and expression analyses with single-nucleotide polymorphisms in TOMM40 in Alzheimer disease. Arch Neurol 68, 1013-1019.
43. Roses AD, Lutz MW, Amrine-Madsen H, Saunders AM, CrenshawDG, Sundseth SS, Huentelman MJ,Welsh-Bohmer KA, Reiman EM (2010) A TOMM40 variable-length polymorphism predicts the age of late-onset Alzheimer's disease. Pharmacogenomics J 10, 375-384.
44. Maruszak A, Peplónska B, Safranow K, Chodakowska-? Zebrowska M, Barcikowska M, Zekanowski C (2012) TOMM40 rs10524523 polymorphism's role in late-onset Alzheimer's disease and in longevity. J Alzheimers Dis 28, 309-322.
45. Freedman ML, Monteiro ANA, Gayther SA, Coetzee GA, Risch A, Plass C, Casey G, De Biasi M, Carlson C, Duggan D, James M, Liu P, Tichelaar JW, Vikis HG, YouM,Mills IG (2011) Principles for the post-GWAS functional characterization of cancer risk loci. Nat Genet 43, 513-518.
46. Rosenbloom KR, Dreszer TR, Long JC, Malladi VS, Sloan CA, Raney BJ, Cline MS, Karolchik D, Barber GP, Clawson H, Diekhans M, Fujita PA, Goldman M, Gravell RC, Harte RA, Hinrichs AS, Kirkup VM, Kuhn RM, Learned K, Maddren M, Meyer LR, Pohl A, Rhead B, Wong MC, Zweig AS, Haussler D, Kent WJ (2011) ENCODE whole-genome data in the UCSC Genome Browser: Update 2012. Nucleic Acids Res 40, D912-D917.
47. Li Y, Grupe A, Rowland C, Nowotny P, Kauwe JSK, Smemo S, Hinrichs A, Tacey K, Toombs TA, Kwok S, Catanese J, White TJ, Maxwell TJ, Hollingworth P, Abraham R, Rubinsztein DC, Brayne C, Wavrant-De Vrieze F, Hardy J, O'Donovan M, Lovestone S, Morris JC, Thal LJ, Owen M, Williams J, Goate A (2006) DAPK1 variants are associated with Alzheimer's disease and allele-specific expression. Hum Mol Genet 15, 2560-2568.
48. Macgregor S (2007) Most pooling variation in array-based DNA pooling is attributable to array error rather than pool construction error. Eur J Hum Genet 15, 501-504.
49. Gaj P, Maryan N, Hennig EE, Ledwon JK, Paziewska A, Majewska A, Karczmarski J, Nesteruk M, Wolski J, Antoniewicz AA, Przytulski K, Rutkowski A, Teumer A, Homuth G, Starzýnska T, Regula J, Ostrowski J (2012) Pooled sample-based GWAS: A cost-effective alternative for identifying colorectal and prostate cancer risk variants in the Polish population. Plos ONE 7, e35307.
50. Ioannidis JPA, Boffetta P, Little J, O'Brien TR, Uitterlinden AG, Vineis P, Balding DJ, Chokkalingam A, Dolan SM, Flanders WD, Higgins JPT, McCarthy MI, McDermott DH, Page GP, Rebbeck TR, Seminara D, Khoury MJ (2008) Assessment of cumulative evidence on genetic associations: Interim guidelines. Int J Epidemiol 37, 120-132.
51. Ioannidis JPA (2008) Effect of formal statistical significance on the credibility of observational associations. Am J Epidemiol 168, 374-383; discussion 384-390.
52. Khoury MJ, Bertram L, Boffetta P, Butterworth AS, Chanock SJ, Dolan SM, Fortier I, Garcia-Closas M, Gwinn M, Hig gins JPT, Janssens ACJW, Ostell J, Owen RP, Pagon RA, Rebbeck TR, Rothman N, Bernstein JL, Burton PR, Campbell H, Chockalingam A, Furberg H, Little J, O'Brien TR, Seminara D, Vineis P,Winn DM, YuW, Ioannidis JPA (2009) Genome-wide association studies, field synopses, and the development of the knowledge base on genetic variation and human diseases. Am J Epidemiol 170, 269-279.
53. Stephens M, Balding DJ (2009) Bayesian statistical methods for genetic association studies. Nat Rev Genet 10, 681-690.